<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------
FORM 8-K/A
AMENDMENT NO. 1 TO
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
----------------------------------
DATE OF EARLIEST EVENT REPORTED: NOVEMBER 1, 2000
INVERNESS MEDICAL TECHNOLOGY, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
DELAWARE 0-20871 04-3164127
---------------------------- ------------------------ -------------------
(STATE OR OTHER JURISDICTION (COMMISSION FILE NUMBER) (IRS EMPLOYER
OF INCORPORATION) IDENTIFICATION NO.)
200 PROSPECT STREET, WALTHAM, MASSACHUSETTS 02453
---------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(781) 647-3900
--------------
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
<PAGE>
ITEM 5 - OTHER EVENTS
This Current Report on Form 8-K/A is filed as an amendment to the
Current Report on Form 8-K filed by Inverness Medical Technology, Inc. event
date November 1, 2000. This Current Report on Form 8-K/A is filed for the
purpose of filing updated financial statements required by Item 7(c).
Page 2
<PAGE>
ITEM 7 - FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
Exhibit 99.2 -- Inverness Medical Technology, Inc. Unaudited Pro
Forma Combined Condensed Financial Statements.
Page 3
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INVERNESS MEDICAL TECHNOLOGY, INC.
/s/ Duane L. James
Date: November 21, 2000 ----------------------------------
Duane L. James
Vice President of Finance
Page 4
<PAGE>
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
Exhibit 99.2 -- Inverness Medical Technology, Inc. Unaudited Pro
Forma Combined Condensed Financial Statements.
Page 5
